Koshinski Asset Management
IDXX icon

Koshinski Asset Management’s Idexx Laboratories IDXX Stock Holding History

Koshinski Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-168
Closed -$91.9K – 1239
2022
Q1 		$91.9K Buy
168
+79
+89% +$41.6K 0.01% 865
2021
Q4 		$58.6K Sell
89
-6
-6% -$3.77K ﹤0.01% 1061
2021
Q3 		$59.1K Buy
+95
New +$63.8K 0.01% 1041

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Koshinski Asset Management's IDXX Position: Q2 2022 in Review

Koshinski Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 168 shares — an estimated $91.9K sold.

Koshinski Asset Management first reported a position in IDXX in Q3 2021 and held it in 3 quarters. The position peaked at $91.9K in Q1 2022. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Koshinski Asset Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 168 Idexx Laboratories shares in Q2 2022, an estimated $91.9K.
  • Koshinski Asset Management first reported a position in Idexx Laboratories in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's Idexx Laboratories position peaked at $91.9K in Q1 2022.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.